Market Size in 2024 | Market Forecast in 2032 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 1642.58 Million | USD 2,912.33 Million | CAGR at 6.57% | 2023 |
According to the report published by Zion Market Research, the global Single Dose Radiotherapy Services Market size was valued at USD 1642.58 Million in 2024 and is predicted to reach USD 2,912.33 Million by the end of 2032. The market is expected to grow with a CAGR of 6.57% during the forecast period.
The report analyzes the global Single Dose Radiotherapy Services Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Single Dose Radiotherapy Services Market industry.
Intraoperative Radiation Therapy (IORT) permits the delivery of a single dose of radiation in the course of surgical operations. This eradicates the requirement of postoperative radiation therapy. Following surgical removal of the tumor, a single high dose of radiation is delivered to the specific region which requires treatment. In this case, surrounding healthy tissues are protected.
The global single dose radiotherapy services market is growing at a significant rate. An increase in the prevalence of cancer, growing adoption of intraoperative radiation therapy, and favorable reimbursement policies are the major factors that are fueling the growth of the global market. Prostate cancer is the most common cancer in America. As per the prediction of the American Cancer Society for 2021, in the United States, there are approximately 248,530 new cases of prostate cancer and nearly 34,130 deaths from prostate cancer. On the other hand, as per the report from WHO, globally there were approximately 2.3 million women diagnosed with breast cancer in 2020.
For the treatment of these cancers, there is massive spending which involves diagnosis, therapy, and routine follow-up. The single dose application carried out with IORT is done at the same time as the surgery. This is significantly advantageous to the patients as there is no need to wait for the healing of the wound after surgery, or plan for radiotherapy. In addition to this, the total duration of the time is reduced and the visit to hospitals is also reduced. This makes the single dose therapy more cost-effective and improves the quality of life of patients. Thus, there is an increase in the adoption of single dose radiotherapy which in turn is spurring the growth of the global single dose radiotherapy services market. Moreover, the rise in the number of clinical trials for single dose radiotherapy for cancer treatment and heavy investments to fulfill the growing demand for cancer treatment is the factors that are boosting the growth of the global market.
Furthermore, technological advancements in the radiotherapy devices and enhance the functionality of the radiotherapy delivery system may lead to several opportunities for the growth of the global single dose radiotherapy services market over the forecast period. However, the lack of skilled professionals to perform single dose radiotherapy may hamper the growth of the global single dose radiotherapy services market.
The global single dose radiotherapy services market is affected by the outbreak of the Covid-19. The rate of adoption of single dose radiotherapy services declined during the pandemic as non-emergency cases were postponed and complete redirection of healthcare workers towards the treatment of Covid-19 patients. In addition to this, patients with low-risk cancer chose to reschedule their therapy with fear of getting infected by visiting the hospitals. This had a negative impact on the market amid the Covid-19 pandemic.
The global single dose radiotherapy services market is segregated based on therapy, application, service provider, and region.
Based on the therapy, the global single dose radiotherapy services market is divided into internal beam radiotherapy and external beam radiotherapy.
The application segment is split into prostate cancer and breast cancer.
The service provider segment consists of specialized cancer institutes, radiotherapy centers, and hospitals.
Report Attributes | Report Details |
---|---|
Report Name | Single Dose Radiotherapy Services Market Research Report |
Market Size in 2024 | USD 1642.58 Million |
Market Forecast in 2032 | USD 2,912.33 Million |
Growth Rate | CAGR of 6.57% |
Number of Pages | 185 |
Key Companies Covered | Panacea Medical Technologies, IsoRay Medical, ViewRay, Elekta, Varian Medical Systems, Ion Beam Applications, Accuray, Provision Healthcare, and Hitachi among others |
Segments Covered | By Therapy, By Application, By Service provider and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Region-wise, North America is projected to hold the maximum share in terms of revenue in the global single dose radiotherapy services market during the forecast period. Factors such as the rise in prevalence of breast & prostate cancer, increase in adoption of single dose radiotherapy owing to its numerous advantages, and presence of technologically advanced radiotherapy devices are augmenting the growth of the market in this region. Asia Pacific region is estimated to grow rapidly due to favorable reimbursement policies, an increase in awareness regarding the benefits of single dose radiotherapy, and an increase in the number of radiotherapy centers.
Some of the key participants that are operating in the global single dose radiotherapy services market are:
By Therapy
By Application
By Service provider
FrequentlyAsked Questions
A treatment approach known as single-dose radiotherapy services entails administering an entire course of radiation therapy to a patient in a single session, as opposed to the fractionated approach that involves delivering radiation in multiple sessions over the course of several days or weeks. Radiotherapy of this nature is occasionally referred to as "single-fraction" or "hypofractionated" radiotherapy.
Continuous progress in radiation therapy technology, characterized by enhanced precision in targeting and diminished adverse effects, has the potential to stimulate the uptake of single-dose radiotherapy services. The adoption of single-dose radiotherapy will be influenced by its efficacy in particular clinical scenarios, including palliative care and specific types of cancer. The market can experience growth due to favorable clinical outcomes and decreased treatment-related complications.
The global Single Dose Radiotherapy Services Market size was valued at USD 1642.58 Million in 2024 and is predicted to reach USD 2,912.33 Million by the end of 2032.
The market is expected to grow with a CAGR of 6.57% during the forecast period.
From a regional perspective, it is anticipated that North America will maintain the largest revenue share of the worldwide single dose radiotherapy services market throughout the projected period. The growth of the market in this region is being bolstered by various factors, including the increasing prevalence of breast and prostate cancer, the growing adoption of single dose radiotherapy due to its manifold benefits, and the availability of technologically advanced radiotherapy devices. The Asia Pacific region is anticipated to experience substantial growth as a result of favorable reimbursement policies, heightened awareness of the advantages of single dose radiotherapy, and a proliferation of radiotherapy centers.
Panacea Medical Technologies, IsoRay Medical, ViewRay, Elekta, Varian Medical Systems, Ion Beam Applications, Accuray, Provision Healthcare, and Hitachi among others
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed